Ameluz treats actinic keratoses on the face and scalp. It is recommended to avoid exposure to the sun for about 48 hours after treatment.
Reviewed: May 31, 2016
Ameluz is a prescription medication used to treat mild to moderate actinic keratoses on the face and scalp. Ameluz is used in combination with photodynamic therapy (PDT) using BF-RhodoLED. BF-RhodoLED, considered a medical device, is a lamp that produces red light and activates the medication.
Ameluz belongs to a group of drugs called a porphyrin precursor. After being activated by BF-RhodoLED, Ameluz destroys the target cells.
This medication is available as a gel and is administered by a health care provider.
Common side effects include applicate site side effects such as pain/burning, irritation, and itching.
How was your experience with ?
Ameluz Drug Class
Ameluz is part of the drug class: